Shanghai Pharmaceuticals Holding Co., Ltd

Related records

Trials (45)

• A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
• A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
• A Clinical Study of B007 in the Treatment of Pemphigus.
• A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
• A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
• A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
• A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
• A Clinical Study of SPH7854 Granules in Healthy Subjects.
• A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
• A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
• A Clinical Study of T3011 in Subjects With Advanced Melanoma
• A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
• A Food Effect Study of SPH5030 Tablets.
• A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
• A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
• A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
• A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
• A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
• B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma
• B002 in Patients With HER2-positive Breast Cancer